ArticleJACC. Case reports2025
A Novel SCN5A Mutation (c.589G>A) Is Associated With Intermittent Atrial Standstill and Conduction System Disease.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSCN5A-associated conduction system disease, though well known, is poorly characterized. CASE SUMMARY: We report a case of a 23-year-old young woman who is a heterozygous carrier of a novel SCN5A c.589G>A (p.Asp197Asn) sequence variation. Phenotypic features in this patient include conduction abnormalities characterized by right bundle branch block, left anterior fascicular block, and a prolonged PR interval at baseline along with symptomatic postexertional pauses and junctional rhythm, likely due to atrial standstill. Her father, who carries the same sequence variation, also has left anterior fascicular block and a prolonged PR interval. The electrocardiographic abnormalities seen in this patient have not progressed over a 7-year follow-up period. DISCUSSION: The above-mentioned phenotypic effects of this novel SCN5A sequence variation have not been characterized before. We hypothesize that the mutation mechanistically acts by slowing down myocardial conduction velocity. TAKE-HOME MESSAGE: A novel SCN5A c.589G>A (p.Asp197Asn) sequence variation is associated with conduction abnormalities and intermittent atrial standstill.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.